Oncotarget

Research Papers:

Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma

Zhi-Zhang Yang _, Hyo Jin Kim, Jose C. Villasboas, Ya-Ping Chen, Tammy Price-Troska, Shahrzad Jalali, Mara Wilson, Anne J. Novak and Stephen M. Ansell

PDF  |  HTML  |  Order a Reprint

Oncotarget. 2017; 8:61425-61439. https://doi.org/10.18632/oncotarget.18251

Metrics: PDF 1027 views  |   HTML 2278 views  |   ?  


Abstract

Zhi-Zhang Yang1, Hyo Jin Kim1, Jose C. Villasboas1, Ya-Ping Chen2, Tammy Price-Troska1, Shahrzad Jalali1, Mara Wilson1, Anne J. Novak1 and Stephen M. Ansell1

1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA

2Division of Oncology/Hematology and Internal Medicine, College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan

Correspondence to:

Zhi-Zhang Yang, email: yang.zhizhang@mayo.edu

Stephen M. Ansell, email: ansell.stephen@mayo.edu

Keywords: follicular lymphoma, LAG-3, T-cell exhaustion, PD-1, immune checkpoint

Received: March 21, 2017     Accepted: April 26, 2017     Published: May 29, 2017

ABSTRACT

Exhausted T-cells in follicular lymphoma (FL) typically express PD-1, but expression of PD-1 is not limited to exhausted cells. Although expected to be functionally suppressed, we found that the population of intratumoral PD-1+ T cells were predominantly responsible for production of cytokines and granules. This surprising finding prompted us to explore the involvement of LAG-3 to specifically identify functionally exhausted T cells. We found that LAG-3 was expressed on a subset of intratumoral T cells from FL and LAG-3+ T cells almost exclusively came from PD-1+ population. CyTOF analysis revealed that intratumoral LAG-3+ T cells were phenotypically heterogeneous as LAG-3 was expressed on a variety of T cell subsets. In contrast to PD-1+LAG-3- cells, intratumoral PD-1+LAG-3+ T cells exhibited reduced capacity to produce cytokines and granules. LAG-3 expression could be substantially upregulated on CD4+ or CD8+ T cells by IL-12, a cytokine that has been shown to induce T-cell exhaustion and be increased in the serum of lymphoma patients. Furthermore, we found that blockade of both PD-1 and LAG-3 signaling enhanced the function of intratumoral CD8+ T cells resulting in increased IFN-γ and IL-2 production. Clinically, LAG-3 expression on intratumoral T cells correlated with a poor outcome in FL patients. Taken together, we find that LAG-3 expression is necessary to identify the population of intratumoral PD-1+ T cells that are functionally exhausted and, in contrast, find that PD-1+LAG-3- T cells are simply activated cells that are immunologically functional. These findings may have important implications for immune checkpoint therapy in FL.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18251